Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription initiation factor TFIID subunit 4 (TAF4) is a large, evolutionarily conserved core component of the TFIID complex, which is essential for the initiation of transcription by RNA polymerase II[1][2][4]. TFIID comprises the TATA-binding protein (TBP) and several TBP-associated factors (TAFs), with TAF4 playing a crucial structural and functional role in maintaining the stability of TFIID, especially as part of a core subcomplex that nucleates formation of the holo-TFIID[2][3]. TAF4 participates in general transcription by aiding promoter recognition, recruiting other general transcription factors, and acting as a coactivator for nuclear receptors like retinoic acid, thyroid hormone, and vitamin D3 receptors[1][4]. It interacts with transcription factor CREB and other proteins with glutamine-rich regions, and abnormal binding to TAF4 has been implicated in the pathogenesis of neurodegenerative polyglutamine diseases[1][4]. Loss or mutation of TAF4 is associated with certain intellectual developmental disorders. Although it is not a direct target of approved drugs, TAF4 is fundamental for transcriptional regulation across cell types and its disruption would have global effects on gene expression[1][3][4].
Not applicable (no drugs directly targeting TAF4), but mechanistically, altering TAF4 function affects transcriptional activation and stability of TFIID complex
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription initiation factor TFIID subunit 4 (TAF4).